We are live on ! Find out more
CRVO icon

CervoMed

12 hedge funds and large institutions have $1.39M invested in CervoMed in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0% more funds holding

Funds holding: 1212 (0)

0% more ownership

Funds ownership: 0.01%0.01% (+0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

25% less capital invested

Capital invested by funds: $1.86M → $1.39M (-$463K)

Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

CRVO Hedge Fund Activity: Q4 2017 in Review

12 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q4 2017, worth a combined $1.39M — down 25% from $1.86M a quarter earlier.

Fund positioning in CRVO was balanced in Q4 2017: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $143K. The largest seller was Millennium Management, exiting entirely with an estimated $66K sold.

  • 12 institutional investors held CervoMed (CRVO) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $1.39M of CervoMed stock for Q4 2017, down 25% quarter-over-quarter.
  • 3 funds opened new CervoMed positions in Q4 2017 and 3 closed out, a net change of 0 holders.
  • The largest CervoMed buyer in Q4 2017 was Vanguard Group, an estimated $143K added.
  • The largest CervoMed seller in Q4 2017 was Millennium Management, an estimated $66K sold.

Based on aggregated 13F filings for Q4 2017.